Log in to save to my catalogue

Sex disparity in secondary prevention pharmacotherapy and clinical outcomes following acute coronary...

Sex disparity in secondary prevention pharmacotherapy and clinical outcomes following acute coronary...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2486468398

Sex disparity in secondary prevention pharmacotherapy and clinical outcomes following acute coronary syndrome

About this item

Full title

Sex disparity in secondary prevention pharmacotherapy and clinical outcomes following acute coronary syndrome

Publisher

England: Oxford University Press

Journal title

European heart journal. Quality of care & clinical outcomes, 2022-06, Vol.8 (4), p.420-428

Language

English

Formats

Publication information

Publisher

England: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Aims
We sought to investigate if sex disparity exists for secondary prevention pharmacotherapy following acute coronary syndrome (ACS) and impact on long-term clinical outcomes.
Methods and results
We analysed data on medical management 30-day post-percutaneous coronary intervention (PCI) for ACS in 20 976 patients within the m...

Alternative Titles

Full title

Sex disparity in secondary prevention pharmacotherapy and clinical outcomes following acute coronary syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2486468398

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2486468398

Other Identifiers

ISSN

2058-5225

E-ISSN

2058-1742

DOI

10.1093/ehjqcco/qcab007

How to access this item